The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...

The NNF – a philanthropic non-profit organisation that owns a controlling stake in Danish drugmaker Novo Nordisk – has been ...

The Synthetic Human Genome (SynHG) Project, launched on the 25th anniversary of the mapping of the human genome, is being ...

Success in this area means ensuring the right therapy reaches the patient in a form that is stable, effective, and ready for ...

To close the innovation-access gap, there is a desperate need for an infrastructure rooted in trust. That means complementing ...

Following a pre-Congress press briefing and data presented onsite at ASCO 2025 itself, pharmaphorum spoke with Dr Victoria ...

An alternative to epinephrine autoinjectors that can be delivered by a nasal spray has been launched in Germany, its first ...

As the CEO of ProofPilot, Chris Venezia has a track record of success with more than 18 years of strong leadership in product ...

Don’t miss the return of the Translational Digital Pathology & AI Summit, uniting 60+ leading biopharma pioneers driving the ...

The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this ...

The JCA process was passed into law by the European Union in 2022. The Joint Clinical Assessment is a process that will ...

Elevidys has been given full approval to treat ambulatory patients with DMD, with an accelerated approval in non-ambulatory ...